A new and dynamic leader in developing a microbiome drug.

From Microbiome to Medicine

Finding links between disease and human microbiome
Microbiome Modulatory Novel Drugs and Functional Food Materials Development for treating diseases

By modulating the microbiome through a self-built screening platform for functional materials and metagenome analyses using NGS (next-generation genomic analysis technology), AtoGen Co., Ltd. is researching and developing new drugs and functional health food materials that can treat various diseases and improve health.


Professional researchers

Research capacity construction for each research theme

Original materials

Targeted therapeutic microbes


Core technology

Screening technics & Whole genome analysis technology

Research infrastructure

Operation of an animal laboratory in the research institute